MGN-3
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jan 2018)
What this means for you
This application is over — abandoned 08 Jan 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85877948
- Mark type
- Stylized text
- Filed
- 15 Mar 2013
- Published for opposition
- 07 Oct 2014
- Abandoned
- 08 Jan 2018
- Attorney of record
- William J. Seiter
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for use as a dietary supplement containing arabinoxylan extract derived from enzymatically modified rice bran to ameliorate immune system deficiency, excluding dietary supplements for muscle growth, sports nutrition, bodybuilding, weight training or athletic training
Owner
- Daiwa Pharmaceutical Co., Ltd., Tokyo 154-0024, JP
- Daiwa Pharmaceutical Co., Ltd., Tokyo, JP
Prosecution history
- 08 Jan 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 08 Jan 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2017 — SOU EXTENSION 5 GRANTED
- 28 Feb 2017 — SOU EXTENSION 5 FILED
- 28 Feb 2017 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Nov 2016 — SOU EXTENSION 4 GRANTED
- 11 Oct 2016 — SOU EXTENSION 4 FILED
- 09 Nov 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Oct 2016 — SOU TEAS EXTENSION RECEIVED
- 11 May 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2016 — SOU EXTENSION 3 GRANTED
- 06 Apr 2016 — SOU EXTENSION 3 FILED
- 04 May 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL